PowerCap / Langhus Energy — real Queensland sodium-ion company, unrealistic direct valuation, and a Langhus wrapper that is genuinely investable under the right structure

§ 01 / WHAT POWERCAP ACTUALLY ISReal company, real product, sub-scale commercial position

PowerCap Un Limited is a Brisbane-headquartered sodium-ion battery company founded by Dane (Ahmed) El Safty, a former Chevron/Shell chemical engineer with prior involvement in shale oil extraction technology. The company has been publicly active since 2020, launched its POD residential product family in late 2024, and has publicly deployed sodium-ion battery systems to Australian residential customers (notably including Zac Efron's northern NSW home), Indonesian commercial and industrial customers (majority of stated ~5MWh lifetime sales), and — as of Aug 2025 — European (Italy, Germany, Spain) and US markets.

§ 02 / THE VALUATION QUESTIONA$613.7M pre-money benchmarked against the market

The pre-money valuation cannot be assessed in isolation. It must be benchmarked against comparable sodium-ion companies, against PowerCap's own commercial traction, and against the state of the sodium-ion category globally in 2026.

Named sodium-ion competitor benchmarks (2026)

The Natron Lesson — technology can work and equity can still go to zero

Pricing benchmark check

The PowerCap deck models revenue at "US$280,000 per MWh blended average" — a claim that requires calibration against 2026 market pricing.

Morgan Stanley TAM claim — what the research actually says

The PowerCap deck cites "Morgan Stanley battery economy research identifies a total addressable market exceeding US$500 billion." The actual Morgan Stanley sodium-ion coverage (Jack Lu et al., June 2026) is more specific:

• Sodium-ion projected to reach 20% of battery deployment market share by 2030, 37% by 2035 (up from 2% in 2027)
• Global sodium-ion market: 830 GWh by 2030, 2.4 TWh by 2035
• US$800 billion in new investment required by 2035 (the "$500B" figure is one interpretation, but the widely-cited number is $800B)
• Sodium-ion 30-40% cheaper than LFP at scale in 2027-28 crossover — not today
• Primary Morgan Stanley-identified beneficiaries: CATL, GM (via Peak Energy US partnership) — Australia not specifically named
• Focus applications: cold-climate storage, commercial vehicle fleets, small passenger EVs, grid storage in northern regions

§ 03 / IP CHAIN OF TITLEThe most urgent diligence issue in the entire opportunity

Forensic patent lookup reveals a chain-of-title issue that should freeze any material investment commitment until resolved.

Broader IP disclosure gaps

The pitch describes 37 licences spanning "cell chemistry & materials, cell manufacturing, energy intelligence, power & storage systems, specialised systems, manufacturing know-how" — but does not name the licensor(s), disclose the terms, provide royalty economics, specify territorial scope, or explain how "exclusive" is defined against 100+ Chinese sodium-ion producers holding overlapping IP. In institutional battery-tech diligence, the licence economics are the deal: royalty rate, cap, buyout, exclusivity carveouts, termination triggers, IP indemnity. None of this is in the document.

§ 04 / PRODUCT PERFORMANCE INCONSISTENCYCycle-count reconciliation required

§ 05 / MANUFACTURING & MARKET REALITIESChina contract lines · CEC approval gap · LFP competitive pressure

Manufacturing capability vs ownership

Manufacturing yield and BOM economics — the diligence beyond capacity claims

"5.2 GWh capability" is a nameplate number. Actual delivered kWh and unit economics depend on manufacturing yield and bill-of-materials cost. Neither is disclosed in the PowerCap raise materials. A 5.2 GWh nominal line running at 95% yield is a very different economic asset from the same line at 80% yield. For a novel sodium-ion chemistry — where yield curves are still being climbed across the industry — this matters.

Yield questions institutional battery-tech diligence would put to PowerCap: first-pass yield, final yield, scrap rate, formation losses, QA rejection rate, line utilisation, takt time, overall equipment effectiveness (OEE), field failure rate. These are the numbers that determine whether the modelled cost per kWh is achievable.

Bill-of-materials questions: "sodium-ion" is a chemistry family, not a chemistry. PowerCap's specific cathode chemistry (Prussian white / layered oxide / polyanionic — for example NFPP, which is what Peak Energy uses), anode composition and source of hard carbon, electrolyte salt and solvent formulation, current collector requirements (aluminium/copper), separator specification, and carbon additive package all drive both material cost and supply-chain security. The "sodium is abundant" strategic thesis becomes irrelevant if a different material dominates the BOM. What matters is BOM $/kWh at commercial yield, benchmarked against LFP ($70/kWh stationary pack, BNEF 2025) and against publicly-reported sodium-ion peer BOMs (HiNa: $70-100/kWh cell per CEO commentary; CATL Naxtra: implied ~$70/kWh cell from the HyperStrong contract pricing).

Cell-level vs system-level performance

PowerCap's certifications (TÜV IEC 62619 for stationary lithium/sodium cells, PPP 51096A for cell-level performance) and its published cycle-life figures (8,000-10,000 cycles depending on which document) are all cell-level or module-level numbers. What Langhus's customers actually buy is a containerised BESS system delivering AC energy over 15+ years. The economic gap between cell-level performance and system-level AC performance is material and needs to be closed in diligence.

System-level questions: usable AC MWh at end-of-warranty; AC-AC round-trip efficiency; parasitic load (BMS, monitoring); auxiliary consumption (HVAC — significant for high ambient); state-of-charge reserve; inverter efficiency (PCS at the PowerCap boundary); annual degradation curve; availability guarantee; augmentation requirement over 15-year life. A cell with 95% coulombic efficiency can become an 85-90% AC system once HVAC parasitic, inverter losses, and system overhead are factored. For BESS project economics — where every point of RTE compounds over thousands of daily cycles — AC-level performance is what pays the bills.

Where sodium-ion wins in 2026

• Cold climate stationary storage — sodium-ion retains >90% capacity at low temperatures; lithium capacity drops ~50%. Morgan Stanley-highlighted primary use case (Scandinavia, northern Europe, Canada, northern US)
• Safety-critical deployments — cement kilns, organic wineries, hospitals, data centres, defence facilities where thermal runaway risk is unacceptable
• Long-cycle grid-tied stationary storage — 4,000-10,000 cycle claims are real for well-designed sodium-ion vs 3,000-6,000 for LFP
• Supply-chain-diversification premium buyers — governments (US FEOC compliance, EU Critical Raw Materials Act), sovereign clients wanting non-Chinese lithium exposure
• Very-remote off-grid installations — where long shelf life at partial state of charge matters

Where sodium-ion currently loses

• Australian residential (material issue for PowerCap) — PowerCap's sodium-ion products do not presently appear to have the required Clean Energy Council (CEC) approved-product listing, which prevents access to the federal battery rebate (~A$300/kWh) and most state incentives under the 2025 Cheaper Home Batteries Program. For a 13.5 kWh system, that is approximately A$4,050 in federal rebate that CEC-listed LFP products receive and PowerCap does not. In a price-sensitive residential market, this is a structural competitive disadvantage until an eligible listing is achieved. The regime is transitioning to SA TS 5398 with battery approval requirements changing through 2026-27, so this is likely to be a PowerCap-specific product approval question rather than an immutable exclusion of sodium chemistry — but the timing and PowerCap's application status are not disclosed in the raise document
• EV applications — energy density insufficient for >400km range vehicles; NMC/NCA still required for premium and long-range
• Portable electronics — volumetric density insufficient
• Direct pure-cost competition with LFP at pack level — LFP $70/kWh vs sodium-ion $100-180/kWh in 2026. Crossover 2027-28 per BNEF/IRENA
• Inverter compatibility — PowerCap's own GM Chris Dryden publicly stated the main barrier to sodium-ion mainstream is "the BMS and compatibility with inverters." Not all Fronius, SolarEdge, Enphase systems work with PowerCap POD without inverter replacement

§ 06 / WARRANTY, PRODUCT LIABILITY & BANKABILITYThe multi-billion-dollar tail risk that early-stage battery balance sheets cannot carry

Battery companies do not merely sell hardware. They sell 10-15 years of future performance liabilities. For a company at PowerCap's stage, and a Langhus wrapper that would put a small-balance-sheet distributor between the manufacturer and the end customer, understanding the full warranty and liability chain is not an ancillary concern — it is central to underwriting.

Warranty bankability

PowerCap offers cycle-based capacity warranties (implied by the "10,000+ cycles" and "≤8,000 cycles at ≥70% retention" performance representations). If the product is sold at US$200/kWh installed and PowerCap achieves 1 GWh of deployed fleet, that is US$200M of installed hardware carrying a 10-15 year warranty obligation. At the Langhus 5-year target of 10 GWh, that is US$2 billion of installed hardware. A small early-stage balance sheet cannot credibly stand behind multi-billion-dollar installed fleet liabilities on its own. Diligence must establish the full warranty chain: who is contractually liable, and who has the financial capacity to honour that liability, at each point?

The warranty chain to be documented: Chinese cell OEM → PowerCap → Langhus → end customer. Institutional battery-tech underwriting requires clarity on: back-to-back manufacturer warranty from the cell OEM (are they contractually liable to PowerCap for the same terms PowerCap offers to Langhus?); PowerCap's warranty reserve (accrual against sales, held in trust or reserve, or naked balance-sheet exposure?); insurance coverage (product liability insurance limit, warranty insurance if any, insurer identity, exclusions); parent guarantee (does any El Safty family entity or other affiliate guarantee?); reinsurance or escrow arrangements; and — critically — insolvency survival: if PowerCap fails, do the warranty rights follow to the customer via the cell OEM, or evaporate?

Product liability and recall exposure

A defective battery is not a software bug. A fleet-wide chemistry defect, a BMS software vulnerability, or a specific product-line failure can create replacement costs, freight, site labour, lost generation revenue, consequential loss claims, regulatory action, and formal recalls. The CEC recall register shows that even major established battery brands can face recall events with substantial cost. For a young company with a thin balance sheet, one systemic defect can destroy equity entirely. Diligence must establish: product liability insurance (limit, insurer, exclusions); recall insurance (limit, trigger, coordination with regulatory authorities); maximum aggregate liability caps in customer contracts; OEM indemnity flowing back from cell manufacturer; warranty reserve accrual methodology.

Bankability of the 800 MWh Power Yield tender

The Langhus wrapper economics depend heavily on converting the Power Yield OÜ 800 MWh German BESS tender from preferred-bidder status to executed supply contract to financeable project. Winning the tender is not the same as delivering a financeable contract. An 800 MWh customer needs assurance that the technology supplier can deliver at spec and remain solvent for 10-15 years — otherwise project lenders reject the technology. Even if Langhus wins preferred-bidder status with PowerCap technology, lenders may say we won't finance this project with PowerCap-supplied cells. That would leave the tender technically won but not financeable — which is a battery-startup trap the Natron collapse (Section 02) exemplifies exactly.

§ 07 / GOVERNANCE & DISCLOSURERed flags in the offer document itself

Disclosure quality — minor observations

Two smaller items sit at the level of disclosure quality rather than substantive red flags but are worth noting: (a) the pitch deck describes CEO Dane El Safty as "Founder | Technology Vision | Principle Engineer" — the correct spelling is Principal Engineer, and a typo of this kind on the CEO's title in a A$613.7M valuation raise document indicates the document has not been through senior legal / advisor review of the standard expected at this valuation; (b) the entity name "PowerCap Un Limited" is a non-standard corporate designation (standard Australian public unlisted company suffix is "Limited" or "Ltd") — trivially resolvable via ASIC search but not proactively disclosed in the raise. Neither is fatal in isolation; both indicate the document has not been through the discipline expected at institutional-raise pricing. Diligence should confirm the ACN, corporate history, name changes, and director register via ASIC extract as a routine step.

§ 08 / THE LANGHUS WRAPPERA materially different instrument than direct PowerCap equity

The Langhus Energy proposition pairs PowerCap technology exposure with Scandinavian exclusive distribution rights, European manufacturing participation (staged US$143M rollout across Aalborg-anchored assembly and cell plants), Australian R&D centre, and BESS project ownership economics. Critically, the entry instrument itself is not ordinary equity — it is structured mezzanine with an equity kicker, which changes the risk-return profile significantly.

The Langhus IP entry instrument structure

What Langhus has actually built

Capital intensity and fully diluted dilution risk

Langhus's stated capital plan totals approximately US$157M across separate buckets: Australian R&D (A$19.85M, ~US$13M), European Phase 1 assembly (US$13.2M), European Phase 2 cell manufacturing + assembly + data centre (US$130M), plus separate BESS project equity, inventory working capital, warranty reserves and potentially PowerCap follow-on participation. The Langhus IP entry investment is scoped at ~A$15M. This means Langhus must raise approximately 10× the entry-round quantum before the platform reaches self-funding free cash flow — and that assumes the 10 GWh Year 5 target is achieved.

A fund taking a 5% Langhus Energy equity kicker today will be materially diluted by these future rounds unless it exercises full pre-emption on every round. Pre-emption is a right, not free anti-dilution — it requires the fund to write additional cheques to preserve percentage. Illustrative ownership waterfall for a 5% initial position, assuming subsequent Langhus rounds of US$15M, US$30M, US$50M and US$100M at progressively higher valuations without pre-emption exercise:

This is why the Return Economics section below distinguishes marked-to-model MOIC from realised cash MOIC — the 5% initial position converts to approximately 3% by the time the platform is at commercial scale, and only pro-rata pre-emption preserves it. Structuring should include pre-emption rights, anti-dilution ratchet on down rounds, and — where possible — either super-pro-rata allocation on future rounds or convertible preferred participation that maintains percentage on conversion.

Technology-provider substitutability — the commercial moat question

Even assuming PowerCap works exactly as represented, the commercial moat question is: why can't Langhus sign CATL, HiNa, BYD or another sodium-ion supplier in two years? If Langhus's value is European relationships, BESS development capability, Aalborg industrial infrastructure, distribution channels, and trading operations, then PowerCap may not be the only possible technology partner. That cuts both ways:

• Reduces PowerCap dependency risk — if PowerCap fails, Langhus's platform value does not automatically go to zero
• Reduces the value of exclusive PowerCap rights — Langhus's willingness to pay a premium for PowerCap exclusivity should be constrained by the availability of alternatives
• Creates an important structural protection to negotiate — the right to substitute alternative sodium-ion (or other chemistry) suppliers if PowerCap fails defined benchmarks

§ 09 / THE 5-YEAR MODELAmbitious rather than conservative

The Langhus 5-year combined model claims US$6.796B Langhus attributable target value at the 10GWh operating scale. Multiple assumptions in the model are aggressive rather than conservative — the label of "very conservative" that accompanies the model is not defensible on close reading.

Headline model output

Specific assumption critiques

Bear case recalibration

US$1.8-2.4B bear case is not a "no" — it is still a significant value. But the range between bear case and target case is 3-4× wide, which is characteristic of very-early-stage venture positions where multiple execution milestones stack. This is important context for underwriting: the bull case is meaningful but should be discounted heavily against the base rate of execution across all these milestones simultaneously.

§ 10 / EXPOSURE FRAMEWORKFour routes to consider

§ 11 / RECOMMENDED TRANSACTION STRUCTUREHow to actually enter this opportunity

The following structure captures the upside of the Langhus wrapper while managing downside through security, tranched drawdown against milestones, and direct PowerCap technology exposure via warrants rather than paying ordinary-share prices.

Total facility size and instrument

Tranche structure and milestone gates

§ 12 / RETURN ECONOMICSUnder recommended structure — marked-to-model vs realised cash

Under the recommended structure (A$10M total drawn as convertible note + 5% Langhus preferred equity + 1.5% PowerCap warrants at A$3.00 strike), the return profile is asymmetric but must be evaluated on two distinct metrics: marked-to-model MOIC (paper valuation at 24 months based on then-current comparables) and realised cash MOIC (actual cash back to the fund via coupon, principal repayment, or exit / secondary sale).

Warrant math — corrected

PowerCap warrants over 1.5% of the post-money 214.4M share base = 3.216M underlying shares. At A$3.00 strike, exercise cost is A$9.65M — the fund must have cash on hand to exercise or must arrange cashless exercise mechanics with PowerCap. Warrant intrinsic value is (share price at time T minus A$3.00) multiplied by 3.216M shares. Correcting the earlier simplified figure:

Return components — 24 months, cash vs marked

§ 13 / DILIGENCE PACKWhat must be verified before Tranche 1 drawdown

§ 14 / FINAL POSITIONRecommendation